ARCHIVES

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

This article is from The Cancer Letter archive.

Vol. 30 No. 20 | May 14, 2004

Download PDF Visit The Full Archive

Related Articles

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977